论文部分内容阅读
目的观察左卡尼汀注射液联合依达拉奉注射液治疗不稳定型心绞痛临床疗效。方法将46例不稳定型心绞痛患者随机分为治疗组和对照组。给予相同的常规治疗,治疗组再此基础上给予左卡尼汀及依达拉奉注射液静点,疗程为14 d,治疗结束后比较心绞痛发作次数、症状发作程度及心电图缺血改善程度。结果治疗组发作次数明显减少,症状明显改善,心电图缺血明显改善,与对照组相比均具有统计学意义P<0.01。结论左卡尼汀联合依达拉奉注射液治疗不稳定型心绞痛安全、疗效显著,值得临床推广。
Objective To observe the clinical efficacy of levocarnitine injection and edaravone injection in the treatment of unstable angina pectoris. Methods 46 patients with unstable angina were randomly divided into treatment group and control group. Given the same routine treatment, the treatment group was given intravenous levocarnitine and edaravone intravenously for a period of 14 days. After the treatment, the number of angina attacks, the degree of symptom onset and the extent of improvement of ECG ischemia were compared. Results The number of attacks in the treatment group was significantly reduced, the symptoms were significantly improved, ischemic electrocardiogram improved significantly, compared with the control group were statistically significant P <0.01. Conclusion L-carnitine combined with edaravone injection in the treatment of unstable angina pectoris is safe and effective, which is worthy of clinical promotion.